GSK (GSK) News Today GBX 1,429 -18.00 (-1.24%) As of 12:16 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesSustainability All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period GSK to sell 500K doses of bird flu vaccines to CanadaFebruary 20 at 10:30 AM | msn.comGSK Shares Gain Over 17% In 5 Days After Major Jump In Q3 ProfitsFebruary 18 at 3:32 AM | msn.comGSK reports FDA approves Penmenvy 5-in-1 meningococcal vaccineFebruary 17, 2025 | markets.businessinsider.comBillionaire’s hedge fund bets big against the GSK share price!February 17, 2025 | msn.comGSK’s Penmenvy meningococcal vaccine gains FDA approvalFebruary 17, 2025 | msn.comGoldman Sachs Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)February 17, 2025 | markets.businessinsider.comHere's Why We're Wary Of Buying GSK's (LON:GSK) For Its Upcoming DividendFebruary 15, 2025 | finance.yahoo.comGSK Q3FY25 Results: Net profit jumps 4X to ₹229 crore; revenue improves 18%February 14, 2025 | msn.comCitadel takes $384.5 million short position in GSK - FTFebruary 14, 2025 | msn.comGSK shares shorted by leading U.S. hedge fund, The Times reportsFebruary 14, 2025 | markets.businessinsider.comGSK plc (LON:GSK) Insider Sells £1,753,088.09 in StockGSK plc (LON:GSK - Get Free Report) insider Emma Walmsley sold 120,653 shares of the company's stock in a transaction on Monday, February 10th. The shares were sold at an average price of GBX 1,453 ($18.09), for a total transaction of £1,753,088.09 ($2,182,086.25).February 13, 2025 | marketbeat.comEmma Walmsley Sells 120,653 Shares of GSK plc (LON:GSK) StockGSK plc (LON:GSK - Get Free Report) insider Emma Walmsley sold 120,653 shares of GSK stock in a transaction on Monday, February 10th. The stock was sold at an average price of GBX 1,453 ($18.09), for a total value of £1,753,088.09 ($2,182,901.37).February 12, 2025 | marketbeat.comUlverston: GSK taskforce aims to allocate £2 million by JuneFebruary 12, 2025 | msn.comAnalysts Set GSK plc (LON:GSK) PT at GBX 1,805.83Shares of GSK plc (LON:GSK - Get Free Report) have been given an average rating of "Moderate Buy" by the seven research firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and fivFebruary 11, 2025 | marketbeat.comGSK sued by Arizona AG for engaging in ‘deceptive’ practicesFebruary 8, 2025 | markets.businessinsider.comGSK plc (LON:GSK) Given Average Rating of "Moderate Buy" by AnalystsShares of GSK plc (LON:GSK - Get Free Report) have been given an average rating of "Moderate Buy" by the seven research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendFebruary 8, 2025 | marketbeat.comGSK launches $2.5 billion buyback, lifts sales target after stellar Q4February 7, 2025 | msn.comGSK Reported Strong Earnings, So I Reiterate My Strong BuyFebruary 7, 2025 | seekingalpha.comGSK is emerging from its long convalescenceFebruary 6, 2025 | ft.comGSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 BillionFebruary 5, 2025 | yahoo.comGSK (LON:GSK) Announces Quarterly Earnings ResultsGSK (LON:GSK - Get Free Report) posted its earnings results on Wednesday. The company reported GBX 23.20 ($0.29) EPS for the quarter. GSK had a return on equity of 33.30% and a net margin of 12.83%.February 5, 2025 | marketbeat.comGSK Sales, Core Earnings Expected to Fall -- Earnings PreviewFebruary 4, 2025 | marketwatch.comEuropean Commission authorizes Vocabria + Rekambys for HIV treatmentFebruary 1, 2025 | markets.businessinsider.comFTSE 100 forecast: BoE decision, Diageo, Vodafone, GSK earningsJanuary 31, 2025 | msn.comIs it game over for the GSK share price?January 31, 2025 | msn.comSheryl Lee Ralph Is Ready to Reunite With Denzel Washington for an ‘Adult Rom-Com’ (Exclusive)January 30, 2025 | msn.comGSK announces new drug applications accepted for review in China, JapanJanuary 28, 2025 | markets.businessinsider.comGSK Pharma put volume heavy and directionally bearishJanuary 28, 2025 | markets.businessinsider.comGSK says asthma and nasal polyps therapy under EU reviewJanuary 28, 2025 | seekingalpha.comGSK's depemokimab under review in China and Japan for asthma, CRSwNPJanuary 28, 2025 | msn.comGSK's depemokimab gets EMA nod for asthma and nasal polypsJanuary 28, 2025 | msn.comGSK, Oxford to establish GSK-Oxford Cancer Immuno-Prevention ProgrammeJanuary 27, 2025 | markets.businessinsider.comGSK announces EMA to review the regulatory application of ShingrixJanuary 27, 2025 | markets.businessinsider.comGSK and University of Oxford researchers to create cancer vaccineJanuary 27, 2025 | lse.co.ukGSK Pharma call volume above normal and directionally bullishJanuary 24, 2025 | markets.businessinsider.comGSK announces expanded EU approval in endometrial cancer for Jemperli comboJanuary 21, 2025 | markets.businessinsider.comEC approves GSK’s Jemperli-chemo combo for endometrial cancerJanuary 21, 2025 | finance.yahoo.comGSK gets EU nod for expanded use of Jemperli in endometrial cancerJanuary 20, 2025 | lse.co.ukGSK rises Friday, still underperforms marketJanuary 17, 2025 | marketwatch.comBrokerages Set GSK plc (LON:GSK) Price Target at GBX 1,805.83GSK plc (LON:GSK - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven research firms that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five haveJanuary 17, 2025 | marketbeat.comJ.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)January 16, 2025 | markets.businessinsider.comGSK To Acquire GIST Drug Developer IDRx For Up To $1.15 Bln CashJanuary 14, 2025 | markets.businessinsider.comGSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 BillionJanuary 14, 2025 | benzinga.comGSK plc (LON:GSK) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of GSK plc (LON:GSK - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold raJanuary 14, 2025 | marketbeat.comGSK CEO on US Expansion, M&A, Drug Pipeline, TrumpJanuary 13, 2025 | finance.yahoo.comGSK CEO Optimistic About Dealmaking, New Trump AdministrationJanuary 13, 2025 | msn.comGSK to buy Boston-based IDRx for $1.15 billionJanuary 13, 2025 | msn.comGSK, Pfizer RSV vaccines to carry warnings of GBS, Reuters reportsJanuary 8, 2025 | markets.businessinsider.comGSK Nears $1 Billion Deal for Biotech Company IDRxJanuary 8, 2025 | msn.comGSK (LON:GSK) Earns Underweight Rating from JPMorgan Chase & Co.JPMorgan Chase & Co. reissued an "underweight" rating on shares of GSK in a research note on Tuesday.January 7, 2025 | marketbeat.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.570.60▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼115▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AZN News Today ITH News Today HCM News Today GRI News Today INDV News Today BMY News Today OGN News Today GPH News Today IGC News Today PHAR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:GSK) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
